Modulation of glucose transporter protein by dietary flavonoids in type 2 diabetes mellitus

International Journal of Biological Sciences

Volumn 11, Issue 5, 2015, Pages 508-524

  Hajiaghaalipour, Fatemeh ^a   Khalilpourfarshbafi, Manizheh ^b   Arya, Aditya ^a,a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITI TEKNOLOGI MARA   (Malaysia)

Author keywords

Flavonoids; Glucose transporter protein; Glucose uptake; Insulin; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; FLAVONOID; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 4; PLANT MEDICINAL PRODUCT;

CHEMISTRY; DIABETES MELLITUS, TYPE 2; DIET; DIETARY SUPPLEMENT; DRUG EFFECTS; HUMAN; METABOLISM; VETERINARY;

DIABETES MELLITUS, TYPE 2; DIET; DIETARY SUPPLEMENTS; FLAVONOIDS; GLUCOSE TRANSPORTER TYPE 2; GLUCOSE TRANSPORTER TYPE 4; HUMANS; HYPOGLYCEMIC AGENTS; PHYTOCHEMICALS;

EID: 84928822710     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.11241     Document Type: Article

References (198)

1. Prabhakar PK, Doble M. Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes. Phytomedicine: international journal of phytotherapy and phytopharmacology. 2009; 16: 1119-26
2. Mohler ML, He Y, Wu Z, Hwang DJ, Miller DD. Recent and emerging anti-diabetes targets. Medicinal research reviews. 2009; 29: 125-95
3. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes research and clinical practice. 2014; 103: 137-49
4. Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes research and clinical practice. 2014; 103: 150-60
5. Lyssenko V, Laakso M. Genetic screening for the risk of type 2 diabetes: worthless or valuable? Diabetes care. 2013; 36 Suppl 2: S120-6
6. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992; 35: 595-601
7. Sarje SK, Ghiware NB, Kawade RM, Gunjkar VN, Vadvalkar SM. ssociation of chronic complications of type 2 diabetes with the biochemical and physical estimations in subjects attending single visit screening for complications. International journal of research in pharmacy and chemistry. 2013; 3: 842-5
8. Bello SO, Chika A, Jimoh AO, Abubakar K, Adebisi I. Evaluation of hypoglycaemic and antihyperglycaemic activity of methanolic wholeplant extract of Schwenckia americana (Solanacae) in normal and alloxan-induced diabetic rats. African journal of pharmacy and pharmacology. 2013; 7: 2662-6
9. Nicolle E, Souard F, Faure P, Boumendjel A. Flavonoids as promising lead compounds in type 2 diabetes mellitus: molecules of interest and structure-activity relationship. Current medicinal chemistry. 2011; 18: 2661-72
10. Kahn SE. The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus. The American journal of medicine. 2000; 108 (Suppl 6a): 2S-8S
11. Zierath JR, He L, Gumà A, Wahlström EO, Klip A, Wallberg-Henriksson H. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia. 1996; 39: 1180-9
12. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. The Journal of clinical investigation. 1999; 103: 253-9
13. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (New York, NY). 1993; 259: 87-91
14. Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H, et al. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. The Journal of biological chemistry. 1997; 272: 29911-8
15. Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). The Journal of biological chemistry. 2000; 275: 9047-54
16. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science (New York, NY). 2004; 306: 457-61
17. Nakatani Y, Kaneto H, Kawamori D, Yoshiuchi K, Hatazaki M, Matsuoka TA, et al. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. The Journal of biological chemistry. 2005; 280: 847-51
18. Ozawa K, Miyazaki M, Matsuhisa M, Takano K, Nakatani Y, Hatazaki M, et al. The endoplasmic reticulum chaperone improves insulin resistance in type 2 diabetes. Diabetes. 2005; 54: 657-63
19. Lin Y, Berg AH, Iyengar P, Lam TK, Giacca A, Combs TP, et al. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. The Journal of biological chemistry. 2005; 280: 4617-26
20. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. The Journal of clinical investigation. 2004; 114: 1752-61
21. Zick Y. Role of Ser/Thr kinases in the uncoupling of insulin signaling. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity. 2003; 27 Suppl 3: S56-60
22. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006; 124: 783-801
23. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. The Journal of clinical investigation. 2006; 116: 1793-801
24. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, et al. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. The Journal of biological chemistry. 2002; 277: 48115-21
25. Gao Z, Zhang X, Zuberi A, Hwang D, Quon MJ, Lefevre M, et al. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Molecular endocrinology (Baltimore, Md). 2004; 18: 2024-34
26. Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature. 1998; 396: 77-80
27. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell. 2000; 103: 239-52
28. Shoelson SE, Lee J, Yuan M. Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity. 2003; 27 Suppl 3: S49-52
29. Kramer D, Shapiro R, Adler A, Bush E, Rondinone CM. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats. Metabolism: clinical and experimental. 2001; 50: 1294-300
30. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. The Journal of biological chemistry. 2002; 277: 50230-6
31. Perseghin G, Petersen K, Shulman GI. Cellular mechanism of insulin resistance: potential links with inflammation. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity. 2003; 27 Suppl 3: S6-11
32. Schmitz-Peiffer C. Protein kinase C and lipid-induced insulin resistance in skeletal muscle. Annals of the New York Academy of Sciences. 2002; 967: 146-57
33. Guillausseau PJ, Meas T, Virally M, Laloi-Michelin M, Medeau V, Kevorkian JP. Abnormalities in insulin secretion in type 2 diabetes mellitus. Diabetes & metabolism. 2008; 34 Suppl 2: S43-8
34. Cernea S, Dobreanu M. Diabetes and beta cell function: from mechanisms to evaluation and clinical implications. Biochemia Medica. 2013;: 266-80
35. Haataja L, Gurlo T, Huang CJ, Butler PC. Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocrine reviews. 2008; 29: 303-16
36. Del Prato S. Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies. Diabetic Medicine. 2009; 26: 1185-92
37. Rivera JF, Costes S, Gurlo T, Glabe CG, Butler PC. Autophagy defends pancreatic β cells from human islet amyloid polypeptide-induced toxicity. The Journal of clinical investigation. 2014; 124: 3489-500
38. Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocrine reviews. 2008; 29: 351-66
39. Wajchenberg BL. beta-cell failure in diabetes and preservation by clinical treatment. Endocrine reviews. 2007; 28: 187-218
40. Yan LJ. Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress. Journal of diabetes research. 2014; 2014: 137919
41. Unger RH, Zhou Y-T, Orci L. Regulation of fatty acid homeostasis in cells: Novel role of leptin. Proceedings of the National Academy of Sciences. 1999; 96: 2327-32
42. Cnop M, Welsh N, Jonas J-C, Jörns A, Lenzen S, Eizirik DL. Mechanisms of Pancreatic β-Cell Death in Type 1 and Type 2 Diabetes: Many Differences, Few Similarities. Diabetes. 2005; 54: S97-S107
43. Yamashita T, Eto K, Okazaki Y, Yamashita S, Yamauchi T, Sekine N, et al. Role of uncoupling protein-2 up-regulation and triglyceride accumulation in impaired glucose-stimulated insulin secretion in a beta-cell lipotoxicity model overexpressing sterol regulatory element-binding protein-1c. Endocrinology. 2004; 145: 3566-77
44. Zhang Q, Ramracheya R, Lahmann C, Tarasov A, Bengtsson M, Braha O, et al. Role of KATP channels in glucose-regulated glucagon secretion and impaired counterregulation in type 2 diabetes. Cell metabolism. 2013; 18: 871-82
45. Gromada J, Franklin I, Wollheim CB. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocrine reviews. 2007; 28: 84-116
46. D'Alessio D. The role of dysregulated glucagon secretion in type 2 diabetes. Diabetes, obesity & metabolism. 2011; 13 Suppl 1: 126-32
47. Meier JJ. The contribution of incretin hormones to the pathogenesis of type 2 diabetes. Best practice & research Clinical endocrinology & metabolism. 2009; 23: 433-41
48. Vilsbøll T, Holst JJ. Incretins, insulin secretion and Type 2 diabetes mellitus. Diabetologia. 2004; 47: 357-66
49. Litwack G. Incretins and Insulin Secretion: Academic Press; 2010
50. Banerjee M, Vats P. Reactive metabolites and antioxidant gene polymorphisms in Type 2 diabetes mellitus. Redox biology. 2013; 2C: 170-7
51. Kassab A, Piwowar A. Cell oxidant stress delivery and cell dysfunction onset in type 2 diabetes. Biochimie. 2012; 94: 1837-48
52. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circulation research. 2010; 107: 1058-70
53. Aronson D. Hyperglycemia and the pathobiology of diabetic complications. Advances in cardiology. 2008; 45: 1-16
54. Cao H, Xie Y, Chen X. Type 2 diabetes diminishes the benefits of dietary antioxidants: Evidence from the different free radical scavenging potential. Food chemistry. 2014
55. Liu YJ, Zhan J, Liu XL, Wang Y, Ji J, He QQ. Dietary flavonoids intake and risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Clinical nutrition (Edinburgh, Scotland). 2014; 33: 59-63
56. van Dam RM, Naidoo N, Landberg R. Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: review of recent findings. Current opinion in lipidology. 2013; 24: 25-33
57. Knekt P, Kumpulainen J, Järvinen R, Rissanen H, Heliövaara M, Reunanen A, et al. Flavonoid intake and risk of chronic diseases. The American Journal of Clinical Nutrition. 2002; 76: 560-8
58. Wedick NM, Pan A, Cassidy A, Rimm EB, Sampson L, Rosner B, et al. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. The American Journal of Clinical Nutrition. 2012; 95: 925-33
59. Cushnie TPT, Lamb AJ. Antimicrobial activity of flavonoids. International Journal of Antimicrobial Agents. 2005; 26: 343-56
60. Beecher GR. Overview of Dietary Flavonoids: Nomenclature, Occurrence and Intake. The Journal of nutrition. 2003; 133: 3248S-54S
61. Castellano G, Gonzalez-Santander JL, Lara A, Torrens F. Classification of flavonoid compounds by using entropy of information theory. Phytochemistry. 2013; 93: 182-91
62. Graf BA, Milbury PE, Blumberg JB. Flavonols, flavones, flavanones, and human health: epidemiological evidence. Journal of medicinal food. 2005; 8: 281-90
63. Arts CI, Hollman CP. Polyphenols and disease risk in epidemiologic studies. The American Journal of Clinical Nutrition. 2005; 81: 317-25
64. de Bock M, Derraik JG, Cutfield WS. Polyphenols and glucose homeostasis in humans. Journal of the Academy of Nutrition and Dietetics. 2012; 112: 808-15
65. Igarashi K, Honma K, Yoshinari O, Nanjo F, Hara Y. Effects of dietary catechins on glucose tolerance, blood pressure and oxidative status in Goto-Kakizaki rats. Journal of nutritional science and vitaminology. 2007; 53: 496-500
66. Grassi D, Desideri G, Necozione S, Lippi C, Casale R, Properzi G, et al. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. The Journal of nutrition. 2008; 138: 1671-6
67. Ruzaidi AMM, Abbe MMJ, Amin I, Nawalyah AG, Muhajir H. Protective effect of polyphenol-rich extract prepared from Malaysian cocoa (Theobroma cacao) on glucose levels and lipid profiles in streptozotocin-induced diabetic rats. Journal of the Science of Food and Agriculture. 2008; 88: 1442-7
68. Vazquez-Prieto MA, Bettaieb A, Haj FG, Fraga CG, Oteiza PI. (-)-Epicatechin prevents TNFalpha-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1 adipocytes. Archives of biochemistry and biophysics. 2012; 527: 113-8
69. Martin MA, Fernandez-Millan E, Ramos S, Bravo L, Goya L. Cocoa flavonoid epicatechin protects pancreatic beta cell viability and function against oxidative stress. Molecular nutrition & food research. 2014; 58: 447-56
70. Anderson RA, Polansky MM. Tea enhances insulin activity. Journal of agricultural and food chemistry. 2002; 50: 7182-6
71. Tipoe GL, Leung TM, Hung MW, Fung ML. Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovascular & hematological disorders drug targets. 2007; 7: 135-44
72. Kao YH, Chang HH, Lee MJ, Chen CL. Tea, obesity, and diabetes. Molecular nutrition & food research. 2006; 50: 188-210
73. Klaus S, Pultz S, Thone-Reineke C, Wolfram S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. International journal of obesity (2005). 2005; 29: 615-23
74. Wolfram S, Wang Y, Thielecke F. Anti-obesity effects of green tea: from bedside to bench. Molecular nutrition & food research. 2006; 50: 176-87
75. Ishikawa A, Yamashita H, Hiemori M, Inagaki E, Kimoto M, Okamoto M, et al. Characterization of inhibitors of postprandial hyperglycemia from the leaves of Nerium indicum. Journal of nutritional science and vitaminology. 2007; 53: 166-73
76. Jo SH, Ka EH, Lee HS, Apostolidis E, Jang HD, Kwon YI. Comparison of Antioxidant Potential and Rat intestinal a-Glucosidases inhibitory Activities of Quercetin, Rutin, and Isoquercetin. International Journal of Applied Research in Natural Products; Vol 2, No 4 (2009). 2009
77. Kim JH, Kang MJ, Choi HN, Jeong SM, Lee YM, Kim JI. Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutrition research and practice. 2011; 5: 107-11
78. Zhang ZF, Lu J, Zheng YL, Wu DM, Hu B, Shan Q, et al. Purple sweet potato color attenuates hepatic insulin resistance via blocking oxidative stress and endoplasmic reticulum stress in high-fat-diet-treated mice. The Journal of nutritional biochemistry. 2013; 24: 1008-18
79. Matsui T, Ebuchi S, Kobayashi M, Fukui K, Sugita K, Terahara N, et al. Anti-hyperglycemic effect of diacylated anthocyanin derived from Ipomoea batatas cultivar Ayamurasaki can be achieved through the alpha-glucosidase inhibitory action. Journal of agricultural and food chemistry. 2002; 50: 7244-8
80. Jung UJ, Lee MK, Jeong KS, Choi MS. The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. The Journal of nutrition. 2004; 134: 2499-503
81. Yin J, Ye J, Jia W. Effects and mechanisms of berberine in diabetes treatment. Acta Pharmaceutica Sinica B. 2012; 2: 327-34
82. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism: clinical and experimental. 2008; 57: 712-7
83. Cazarolli LH, Pereira DF, Kappel VD, Folador P, Figueiredo Mdos S, Pizzolatti MG, et al. Insulin signaling: a potential signaling pathway for the stimulatory effect of kaempferitrin on glucose uptake in skeletal muscle. European journal of pharmacology. 2013; 712: 1-7
84. Ong KC, Khoo HE. Effects of myricetin on glycemia and glycogen metabolism in diabetic rats. Life sciences. 2000; 67: 1695-705
85. Jorge AP, Horst H, de Sousa E, Pizzolatti MG, Silva FR. Insulinomimetic effects of kaempferitrin on glycaemia and on 14C-glucose uptake in rat soleus muscle. Chemico-biological interactions. 2004; 149: 89-96
86. Mueckler M, Caruso C, Baldwin SA, Panico M, Blench I, Morris HR, et al. Sequence and structure of a human glucose transporter. Science (New York, NY). 1985; 229: 941-5
87. Mueckler M, Thorens B. The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med. 2013; 34: 121-38
88. Baldwin SA, Lienhard GE. Purification and reconstitution of glucose transporter from human erythrocytes. Methods in enzymology. 1989; 174: 39-50
89. Kasahara M, Hinkle PC. Reconstitution and purification of the D-glucose transporter from human erythrocytes. The Journal of biological chemistry. 1977; 252: 7384-90
90. Birnbaum MJ, Haspel HC, Rosen OM. Cloning and characterization of a cDNA encoding the rat brain glucose-transporter protein. Proceedings of the National Academy of Sciences of the United States of America. 1986; 83: 5784-8
91. Shetty M, Loeb JN, Vikstrom K, Ismail-Beigi F. Rapid activation of GLUT-1 glucose transporter following inhibition of oxidative phosphorylation in clone 9 cells. The Journal of biological chemistry. 1993; 268: 17225-32
92. Rubin D, Ismail-Beigi F. Distribution of Glut1 in detergent-resistant membranes (DRMs) and non-DRM domains: effect of treatment with azide. American journal of physiology Cell physiology. 2003; 285: C377-83
93. Barros LF, Barnes K, Ingram JC, Castro J, Porras OH, Baldwin SA. Hyperosmotic shock induces both activation and translocation of glucose transporters in mammalian cells. Pflugers Archiv: European journal of physiology. 2001; 442: 614-21
94. Barnes K, Ingram JC, Porras OH, Barros LF, Hudson ER, Fryer LG, et al. Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). Journal of cell science. 2002; 115: 2433-42
95. Louters LL, Dyste SG, Frieswyk D, Tenharmsel A, Vander Kooy TO, Walters L, et al. Methylene blue stimulates 2-deoxyglucose uptake in L929 fibroblast cells. Life sciences. 2006; 78: 586-91
96. Kumar A, Xiao YP, Laipis PJ, Fletcher BS, Frost SC. Glucose deprivation enhances targeting of GLUT1 to lipid rafts in 3T3-L1 adipocytes. American journal of physiology Endocrinology and metabolism. 2004; 286: E568-76
97. Roelofs B, Tidball A, Lindborg AE, TenHarmsel A, Vander Kooy TO, Louters LL. Acute activation of glucose uptake by glucose deprivation in L929 fibroblast cells. Biochimie. 2006; 88: 1941-6
98. Cok A, Plaisier C, Salie MJ, Oram DS, Chenge J, Louters LL. Berberine acutely activates the glucose transport activity of GLUT1. Biochimie. 2011; 93: 1187-92
99. Kim SH, Shin EJ, Kim ED, Bayaraa T, Frost SC, Hyun CK. Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes. Biological & pharmaceutical bulletin. 2007; 30: 2120-5
100. Lee MS, Kim CH, Hoang DM, Kim BY, Sohn CB, Kim MR, et al. Genistein-derivatives from Tetracera scandens stimulate glucose-uptake in L6 myotubes. Biological & pharmaceutical bulletin. 2009; 32: 504-8
101. Kellett GL, Brot-Laroche E, Mace OJ, Leturque A. Sugar absorption in the intestine: the role of GLUT2. Annual review of nutrition. 2008; 28: 35-54
102. Cramer SC, Pardridge WM, Hirayama BA, Wright EM. Colocalization of GLUT2 glucose transporter, sodium/glucose cotransporter, and gamma-glutamyl transpeptidase in rat kidney with double-peroxidase immunocytochemistry. Diabetes. 1992; 41: 766-70
103. Mounien L, Marty N, Tarussio D, Metref S, Genoux D, Preitner F, et al. Glut2-dependent glucose-sensing controls thermoregulation by enhancing the leptin sensitivity of NPY and POMC neurons. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2010; 24: 1747-58
104. Garcia M, Millan C, Balmaceda-Aguilera C, Castro T, Pastor P, Montecinos H, et al. Hypothalamic ependymal-glial cells express the glucose transporter GLUT2, a protein involved in glucose sensing. Journal of neurochemistry. 2003; 86: 709-24
105. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nature genetics. 2010; 42: 105-16
106. Burcelin R, Dolci W, Thorens B. Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice. Diabetes. 2000; 49: 1643-8
107. Uldry M, Ibberson M, Hosokawa M, Thorens B. GLUT2 is a high affinity glucosamine transporter. FEBS letters. 2002; 524: 199-203
108. Bonny C, Roduit R, Gremlich S, Nicod P, Thorens B, Waeber G. The loss of GLUT2 expression in the pancreatic beta-cells of diabetic db/db mice is associated with an impaired DNA-binding activity of islet-specific trans-acting factors. Molecular and cellular endocrinology. 1997; 135: 59-65
109. Okamoto Y, Tanaka S, Haga Y. Enhanced GLUT2 gene expression in an oleic acid-induced in vitro fatty liver model. Hepatology Research. 2002; 23: 138-44
110. Jung UJ, Lee MK, Park YB, Kang MA, Choi MS. Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. The international journal of biochemistry & cell biology. 2006; 38: 1134-45
111. Cordero-Herrera I, Martin MA, Goya L, Ramos S. Cocoa flavonoids attenuate high glucose-induced insulin signalling blockade and modulate glucose uptake and production in human HepG2 cells. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association. 2014; 64: 10-9
112. Cordero-Herrera I, Martin MA, Bravo L, Goya L, Ramos S. Cocoa flavonoids improve insulin signalling and modulate glucose production via AKT and AMPK in HepG2 cells. Molecular nutrition & food research. 2013; 57: 974-85
113. Simpson IA, Dwyer D, Malide D, Moley KH, Travis A, Vannucci SJ. The facilitative glucose transporter GLUT3: 20 years of distinction. American journal of physiology Endocrinology and metabolism. 2008; 295: E242-53
114. Boileau P, Mrejen C, Girard J, Hauguel-de Mouzon S. Overexpression of GLUT3 placental glucose transporter in diabetic rats. The Journal of clinical investigation. 1995; 96: 309-17
115. Brown K, Heller DS, Zamudio S, Illsley NP. Glucose transporter 3 (GLUT3) protein expression in human placenta across gestation. Placenta. 2011; 32: 1041-9
116. Gould GW, Holman GD. The glucose transporter family: structure, function and tissue-specific expression. Biochemical Journal. 1993; 295: 329-41
117. Apelt J, Mehlhorn G, Schliebs R. Insulin-sensitive GLUT4 glucose transporters are colocalized with GLUT3-expressing cells and demonstrate a chemically distinct neuron-specific localization in rat brain. Journal of Neuroscience Research. 1999; 57: 693–705
118. Brosius FC, 3rd, Briggs JP, Marcus RG, Barac-Nieto M, Charron MJ. Insulin-responsive glucose transporter expression in renal microvessels and glomeruli. Kidney international. 1992; 42: 1086-92
119. Huang S, Czech MP. The GLUT4 Glucose Transporter. Cell metabolism. 2007; 5: 237-52
120. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature. 2001; 409: 729-33
121. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005; 436: 356-62
122. Kahn BB. Glucose Transport: Pivotal Step in Insulin Action. American Diabetes Association. 1996; 45: 1644-54
123. Zhidan W, Xie Y, Morrison RF, Bucher NL, Farmer SR. PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes. The Journal of clinical investigation. 1998; 101: 22-32 124
124. Jing D, Xian Z, Lei Z, Hui-Xi B, Xu N, Bin B, et al. Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: amechanismincluding AMPKα1/SIRT1. Journal of Lipid Research. 2014; 55: 363–74
125. Leto D, Saltiel AR. Regulation of glucose transport by insulin: traffic control of GLUT4. Nature reviews Molecular cell biology. 2012; 13: 383-96
126. Alam MM, Meerza D, Naseem I. Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. Life sciences. 2014; 109: 8-14
127. Yamashita Y, Okabe M, Natsume M, Ashida H. Comparison of Anti-Hyperglycemic Activities Between Low- and High-Degree of Polymerization Procyanidin Fractions from Cacao Liquor Extract. Journal of Food and Drug Analysis. 2012; 20: 283-7
128. Yamashita Y, Okabe M, Natsume M, Ashida H. Cacao liquor procyanidin extract improves glucose tolerance by enhancing GLUT4 translocation and glucose uptake in skeletal muscle. Journal of nutritional science. 2012; 1: e2
129. Matsuda H, Kogami Y, Nakamura S, Sugiyama T, Ueno T, Yoshikawa M. Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells. Bioorganic & medicinal chemistry. 2011; 19: 2835-41
130. Vishnu Prasad CN, Anjana T, Banerji A, Gopalakrishnapillai A. Gallic acid induces GLUT4 translocation and glucose uptake activity in 3T3-L1 cells. FEBS letters. 2010; 584: 531-6
131. Ueda M, Nishiumi S, Nagayasu H, Fukuda I, Yoshida K, Ashida H. Epigallocatechin gallate promotes GLUT4 translocation in skeletal muscle. Biochemical and biophysical research communications. 2008; 377: 286-90
132. Zygmunt K, Faubert B, MacNeil J, Tsiani E. Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK. Biochemical and biophysical research communications. 2010; 398: 178-83
133. Klover PJ, Mooney RA. Hepatocytes: critical for glucose homeostasis. The international journal of biochemistry & cell biology. 2004; 36: 753-8
134. Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol. 2011; 13: 1016-23
135. Hardie DG. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes & development. 2011; 25: 1895-908
136. Rutter GA. Nutrient–secretion coupling in the pancreatic islet β-cell: recent advances. Molecular Aspects of Medicine. 2001; 22: 247-84
137. Rutter GA. Visualising insulin secretion. The Minkowski Lecture 2004. Diabetologia. 2004; 47: 1861-72
138. Schnell S, Schaefer M, Schofl C. Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40. Molecular and cellular endocrinology. 2007; 263: 173-80
139. Lin CL, Lin JK. Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells. Molecular nutrition & food research. 2008; 52: 930-9
140. Li Y, Zhao S, Zhang W, Zhao P, He B, Wu N, et al. Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo. Diabetes research and clinical practice. 2011; 93: 205-14
141. Zhang ZF, Li Q, Liang J, Dai XQ, Ding Y, Wang JB, et al. Epigallocatechin-3-O-gallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition. Phytomedicine: international journal of phytotherapy and phytopharmacology. 2010; 17: 14-8
142. Lou T, Zhang Z, Xi Z, Liu K, Li L, Liu B, et al. Berberine inhibits inflammatory response and ameliorates insulin resistance in hepatocytes. Inflammation. 2011; 34: 659-67
143. Kappel VD, Cazarolli LH, Pereira DF, Postal BG, Zamoner A, Reginatto FH, et al. Involvement of GLUT-4 in the stimulatory effect of rutin on glucose uptake in rat soleus muscle. The Journal of pharmacy and pharmacology. 2013; 65: 1179-86
144. Kappel VD, Zanatta L, Postal BG, Silva FR. Rutin potentiates calcium uptake via voltage-dependent calcium channel associated with stimulation of glucose uptake in skeletal muscle. Archives of biochemistry and biophysics. 2013; 532: 55-60
145. Tzeng TF, Liou SS, Liu IM. Myricetin Ameliorates Defective Post-Receptor Insulin Signaling via beta-Endorphin Signaling in the Skeletal Muscles of Fructose-Fed Rats. Evidence-based complementary and alternative medicine: eCAM. 2011; 2011: 150752
146. Liu IM, Tzeng TF, Liou SS, Lan TW. Myricetin, a naturally occurring flavonol, ameliorates insulin resistance induced by a high-fructose diet in rats. Life sciences. 2007; 81: 1479-88
147. Pinent M, Blay M, Bladé MC, Salvadó MJ, Arola L, Ardévol A. Grape Seed-Derived Procyanidins Have an Antihyperglycemic Effect in Streptozotocin-Induced Diabetic Rats and Insulinomimetic Activity in Insulin-Sensitive Cell Lines. Endocrinology. 2004; 145: 4985-90
148. Park CE, Kim MJ, Lee JH, Min BI, Bae H, Choe W, et al. Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase. Experimental & molecular medicine. 2007; 39: 222-9
149. Asano K, Takagi K, Haneishi A, Nakamura S, Yamada K. (-)-Epigallocatechin-3-gallate stimulates both AMP-activated protein kinase and nuclear factor-kappa B signaling pathways. Food chemistry. 2012; 134: 783-8
150. Li Y, Ding Y. Minireview: Therapeutic potential of myricetin in diabetes mellitus. Food Science and Human Wellness. 2012; 1: 19-25
151. Murase T, Misawa K, Haramizu S, Hase T. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochemical pharmacology. 2009; 78: 78-84
152. Pu P, Gao DM, Mohamed S, Chen J, Zhang J, Zhou XY, et al. Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet. Archives of biochemistry and biophysics. 2012; 518: 61-70
153. Brusq JM, Ancellin N, Grondin P, Guillard R, Martin S, Saintillan Y, et al. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. J Lipid Res. 2006; 47: 1281-8
154. Cheng Z, Pang T, Gu M, Gao AH, Xie CM, Li JY, et al. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. Biochimica et biophysica acta. 2006; 1760: 1682-9
155. Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006; 55: 2256-64
156. Yin J, Gao Z, Liu D, Liu Z, Ye J. Berberine improves glucose metabolism through induction of glycolysis. American journal of physiology Endocrinology and metabolism. 2008; 294: E148-56
157. Ding Y, Dai X-q, Zhang Z-f, Li Y. Myricetin attenuates hyperinsulinemia-induced insulin resistance in skeletal muscle cells. European Food Research and Technology. 2012; 234: 873-81
158. Cazarolli LH, Folador P, Moresco HH, Brighente IM, Pizzolatti MG, Silva FR. Stimulatory effect of apigenin-6-C-beta-L-fucopyranoside on insulin secretion and glycogen synthesis. European journal of medicinal chemistry. 2009; 44: 4668-73
159. Cazarolli LH, Kappel VD, Pereira DF, Moresco HH, Brighente IM, Pizzolatti MG, et al. Anti-hyperglycemic action of apigenin-6-C-beta-fucopyranoside from Averrhoa carambola. Fitoterapia. 2012; 83: 1176-83
160. Vessal M, Hemmati M, Vasei M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comparative biochemistry and physiology Toxicology & pharmacology: CBP. 2003; 135C: 357-64
161. Scazzocchio B, Vari R, Filesi C, D'Archivio M, Santangelo C, Giovannini C, et al. Cyanidin-3-O-beta-glucoside and protocatechuic acid exert insulin-like effects by upregulating PPARgamma activity in human omental adipocytes. Diabetes. 2011; 60: 2234-44
162. Adisakwattana S, Charoenlertkul P, Yibchok-Anun S. alpha-Glucosidase inhibitory activity of cyanidin-3-galactoside and synergistic effect with acarbose. Journal of enzyme inhibition and medicinal chemistry. 2009; 24: 65-9
163. Nizamutdinova IT, Jin YC, Chung JI, Shin SC, Lee SJ, Seo HG, et al. The anti-diabetic effect of anthocyanins in streptozotocin-induced diabetic rats through glucose transporter 4 regulation and prevention of insulin resistance and pancreatic apoptosis. Molecular nutrition & food research. 2009; 53: 1419-29
164. Takikawa M, Inoue S, Horio F, Tsuda T. Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. The Journal of nutrition. 2010; 140: 527-33
165. Zhang ZF, Lu J, Zheng Y-l, Hu B, Fan S-h, Wu D-m, et al. Purple sweet potato color protects mouse liver against d-galactose-induced apoptosis via inhibiting caspase-3 activation and enhancing PI3K/Akt pathway. Food and Chemical Toxicology. 2010; 48: 2500-7
166. Zhang ZF, Fan SH, Zheng YL, Lu J, Wu DM, Shan Q, et al. Purple sweet potato color attenuates oxidative stress and inflammatory response induced by d-galactose in mouse liver. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association. 2009; 47: 496-501
167. Mahmoud AM, Ashour MB, Abdel-Moneim A, Ahmed OM. Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. Journal of diabetes and its complications. 2012; 26: 483-90
168. Ahmed OM, Mahmoud AM, Abdel-Moneim A, Ashour MB. Antihyperglycemic and Antihyperlipidemic Effects of Hesperidin and Naringin in High Fat Diet/Streptozotocin Type 2 Diabetic Rats. Life Science Journal. 2011; 8: 91-101
169. Ghosh D, Konishi T. Anthocyanins and anthocyanin-rich extracts: role in diabetes and eye function. Asia Pacific journal of clinical nutrition. 2007; 16: 200-8
170. Stewart AJ, Bozonnet S, Mullen W, Jenkins GI, Lean ME, Crozier A. Occurrence of flavonols in tomatoes and tomato-based products. Journal of agricultural and food chemistry. 2000; 48: 2663-9
171. Hertog MGL, Hollman PCH, Katan MB. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. Journal of agricultural and food chemistry. 1992; 40: 2379-83
172. Erdman JW, Jr., Balentine D, Arab L, Beecher G, Dwyer JT, Folts J, et al. Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC. The Journal of nutrition. 2007; 137: 718S-37S
173. López M, Martinez F, Del Valle C, Orte C, Miró M. Analysis of phenolic constituents of biological interest in red wines by high-performance liquid chromatography. Journal of Chromatography A. 2001; 922: 359-63
174. Jeon SM, Park YB, Choi MS. Antihypercholesterolemic property of naringin alters plasma and tissue lipids, cholesterol-regulating enzymes, fecal sterol and tissue morphology in rabbits. Clinical nutrition (Edinburgh, Scotland). 2004; 23: 1025-34
175. Kim HJ, Oh GT, Park YB, Lee MK, Seo HJ, Choi MS. Naringin alters the cholesterol biosynthesis and antioxidant enzyme activities in LDL receptor-knockout mice under cholesterol fed condition. Life sciences. 2004; 74: 1621-34
176. Miyake Y, Shimoi K, Kumazawa S, Yamamoto K, Kinae N, Osawa T. Identification and antioxidant activity of flavonoid metabolites in plasma and urine of eriocitrin-treated rats. Journal of agricultural and food chemistry. 2000; 48: 3217-24
177. He J, Giusti MM. Anthocyanins: natural colorants with health-promoting properties. Annual review of food science and technology. 2010; 1: 163-87
178. Kreft S, Knapp M, Kreft I. Extraction of rutin from buckwheat (Fagopyrum esculentumMoench) seeds and determination by capillary electrophoresis. Journal of agricultural and food chemistry. 1999; 47: 4649-52
179. Crozier A, Jaganath IB, Clifford MN. Dietary phenolics: chemistry, bioavailability and effects on health. Natural product reports. 2009; 26: 1001-43
180. Reinli K, Block G. Phytoestrogen content of foods--a compendium of literature values. Nutrition and cancer. 1996; 26: 123-48
181. Veitch NC. Isoflavonoids of the leguminosae. Natural product reports. 2013; 30: 988-1027
182. Martineau LC, Couture A, Spoor D, Benhaddou-Andaloussi A, Harris C, Meddah B, et al. Anti-diabetic properties of the Canadian lowbush blueberry Vaccinium angustifolium Ait. Phytomedicine: international journal of phytotherapy and phytopharmacology. 2006; 13: 612-23
183. Sasaki R, Nishimura N, Hoshino H, Isa Y, Kadowaki M, Ichi T, et al. Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice. Biochemical pharmacology. 2007; 74: 1619-27
184. Guo H, Xia M, Zou T, Ling W, Zhong R, Zhang W. Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1. The Journal of nutritional biochemistry. 2012; 23: 349-60
185. Inaguma T, Han J, Isoda H. Improvement of insulin resistance by Cyanidin 3-glucoside, anthocyanin from black beans through the up-regulation of GLUT4 gene expression. BMC Proceedings. 2011; 5: P21
186. Daisy P, Balasubramanian K, Rajalakshmi M, Eliza J, Selvaraj J. Insulin mimetic impact of Catechin isolated from Cassia fistula on the glucose oxidation and molecular mechanisms of glucose uptake on Streptozotocin-induced diabetic Wistar rats. Phytomedicine: international journal of phytotherapy and phytopharmacology. 2010; 17: 28-36
187. Ueda M, Furuyashiki T, Yamada K, Aoki Y, Sakane I, Fukuda I, et al. Tea catechins modulate the glucose transport system in 3T3-L1 adipocytes. Food & function. 2010; 1: 167-73
188. Yan J, Zhao Y, Suo S, Liu Y, Zhao B. Green tea catechins ameliorate adipose insulin resistance by improving oxidative stress. Free radical biology & medicine. 2012; 52: 1648-57
189. Bao S, Cao Y, Fan C, Fan Y, Bai S, Teng W, et al. Epigallocatechin gallate improves insulin signaling by decreasing toll-like receptor 4 (TLR4) activity in adipose tissues of high-fat diet rats. Molecular nutrition & food research. 2014; 58: 677-86
190. Hossain. Apigenin Causes Biochemical Modulation, Glut4 and Cd38 Alterations to Improve Diabetes and to Protect Damages of Some Vital Organs in Experimental Diabetes. American Journal of Pharmacology and Toxicology. 2014; 9: 39-52
191. Ong KW, Hsu A, Song L, Huang D, Tan BK. Polyphenols-rich Vernonia amygdalina shows anti-diabetic effects in streptozotocin-induced diabetic rats. Journal of ethnopharmacology. 2011; 133: 598-607
192. Kim MS, Hur HJ, Kwon DY, Hwang J-T. Tangeretin stimulates glucose uptake via regulation of AMPK signaling pathways in C2C12 myotubes and improves glucose tolerance in high-fat diet-induced obese mice. Molecular and cellular endocrinology. 2012; 358: 127-34
193. Onda K, Horike N, Suzuki T, Hirano T. Polymethoxyflavonoids tangeretin and nobiletin increase glucose uptake in murine adipocytes. Phytotherapy research: PTR. 2013; 27: 312-6
194. Prasath GS, Pillai SI, Subramanian SP. Fisetin improves glucose homeostasis through the inhibition of gluconeogenic enzymes in hepatic tissues of streptozotocin induced diabetic rats. European journal of pharmacology. 2014; 740: 248-54
195. Fang XK, Gao J, Zhu DN. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity. Life sciences. 2008; 82: 615-22
196. Cazarolli LH, Folador P, Pizzolatti MG, Mena Barreto Silva FR. Signaling pathways of kaempferol-3-neohesperidoside in glycogen synthesis in rat soleus muscle. Biochimie. 2009; 91: 843-9
197. Paoli P, Cirri P, Caselli A, Ranaldi F, Bruschi G, Santi A, et al. The insulin-mimetic effect of Morin: a promising molecule in diabetes treatment. Biochimica et biophysica acta. 2013; 1830: 3102-11
198. Kandasamy N, Ashokkumar N. Protective effect of bioflavonoid myricetin enhances carbohydrate metabolic enzymes and insulin signaling molecules in streptozotocin-cadmium induced diabetic nephrotoxic rats. Toxicology and applied pharmacology. 2014; 279: 173-85.